Abstract
Aims:
Adiposity is associated with an increased but also with a decreased risk for successive vascular events or mortality in patients with different manifestations of vascular disease. In this study we directly compare the risk of general adiposity or abdominal obesity on the occurrence of new vascular events or mortality in these patients.
Methods:
Patients with cerebrovascular disease (CVD; n=973), coronary artery disease (CAD; n=2339) or peripheral arterial disease (PAD; n=894) were prospectively followed for the occurrence of a vascular event or death. The median follow-up was 4.5 years. Adiposity was assessed with body mass index (BMI), waist circumference (WC) and determination of intra-abdominal fat through ultrasound. Cox proportional hazards models were used to evaluate the risk for new vascular events, vascular mortality and all-cause mortality.
Results:
CAD patients had a 12% increased risk for vascular mortality with 1 BMI unit increase (hazard ratio (HR) 1.12; 95% confidence interval (CI) 1.05–1.20) and a 25% increased risk with 1cm increase in intra-abdominal adipose tissue (HR 1.25; 95% CI 1.12–1.39). The risk for all-cause mortality was increased by 3% (HR 1.03; 95% CI 1.01–1.05) with 1 cm increase in WC and was increased by 15% (HR 1.15; 95% CI 1.06–1.25) with 1 cm increase in intra-abdominal adipose tissue. In PAD patients there was an inverse relationship between BMI and vascular mortality (HR 0.93; 95% CI 0.87–0.98) and all-cause mortality (HR 0.90; 95% CI 0.86–0.94). In CVD patients there was no relation between obesity and vascular events or mortality.
Conclusion:
General adiposity is associated with an increased risk for vascular mortality in CAD patients and a decreased risk for (vascular) mortality in PAD patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008; 359: 2105–2120.
Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB . Years of life lost due to obesity. JAMA 2003; 289: 187–193.
Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006; 355: 763–778.
Stolk RP, Wink O, Zelissen PM, Meijer R, van Gils AP, Grobbee DE . Validity and reproducibility of ultrasonography for the measurement of intra-abdominal adipose tissue. Int J Obes Relat Metab Disord 2001; 25: 1346–1351.
Haslam DW, James WP . Obesity. Lancet 2005; 366: 1197–1209.
Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T et al. Heart disease and stroke statistics—2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006; 113: e85–e151.
Strazzullo P, D’Elia L, Cairella G, Garbagnati F, Cappuccio FP, Scalfi L . Excess body weight and incidence of stroke: meta-analysis of prospective studies with 2 million participants. Stroke 2010; 41: e418–e426.
Eckel RH, Krauss RM . American Heart Association call to action: obesity as a major risk factor for coronary heart disease. Circulation 1998; 97: 2099–2100.
Lavie CJ, Milani RV, Ventura HO . Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009; 53: 1925–1932.
Lu B, Zhou J, Waring ME, Parker DR, Eaton CB . Abdominal obesity and peripheral vascular disease in men and women: a comparison of waist-to-thigh ratio and waist circumference as measures of abdominal obesity. Atherosclerosis 2010; 208: 253–257.
Freiberg MS, Pencina MJ, D’Agostino RB, Lanier K, Wilson PW, Vasan RS . BMI vs. waist circumference for identifying vascular risk. Obesity (Silver Spring) 2008; 16: 463–469.
Emerging Risk Factors Collaboration, Wormser D, Kaptoge S, Di Angelantonio E, Wood AM, Pennells L et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet 2011; 377: 1085–1095.
Towfighi A, Ovbiagele B . The impact of body mass index on mortality after stroke. Stroke 2009; 40: 2704–2708.
Vickrey BG, Rector TS, Wickstrom SL, Guzy PM, Sloss EM, Gorelick PB et al. Occurrence of secondary ischemic events among persons with atherosclerotic vascular disease. Stroke 2002; 33: 901–906.
Brass LM, Hartigan PM, Page WF, Concato J . Importance of cerebrovascular disease in studies of myocardial infarction. Stroke 1996; 27: 1173–1176.
Achterberg S, Cramer MJ, Kappelle LJ, de Borst GJ, Visseren FL, van der Graaf Y et al. Patients with coronary, cerebrovascular or peripheral arterial obstructive disease differ in risk for new vascular events and mortality: the SMART study. Eur J Cardiovasc Prev Rehabil 2010; 17: 424–430.
Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. Circulation 2006; 113: e409–e449.
Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001; 286: 1317–1324.
Steg PG, Bhatt DL, Wilson PW, D’Agostino Sr R, Ohman EM, Röther J et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007; 297: 1197–1206.
Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 2006; 368: 666–678.
Barba R, Bisbe J, Pedrajas JN, Toril J, Monte R, Muñoz-Torrero JF et al. Body mass index and outcome in patients with coronary, cerebrovascular, or peripheral artery disease: findings from the FRENA registry. Eur J Cardiovasc Prev Rehabil 2009; 16: 457–463.
Simons PC, Algra A, van de Laak MF, Grobbee DE, van der Graaf Y . Second manifestations of ARTerial disease (SMART) study: rationale and design. Eur J Epidemiol 1999; 15: 773–781.
Schnabel R, Messow CM, Lubos E, Espinola-Klein C, Rupprecht HJ, Bickel C et al. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene. Eur Heart J 2008; 29: 649–657.
Giugliano G, Brevetti G, Laurenzano E, Brevetti L, Luciano R, Chiariello M . The prognostic impact of general and abdominal obesity in peripheral arterial disease. Int J Obes (Lond) 2010; 34: 280–286.
Galal W, van Gestel YR, Hoeks SE, Sin DD, Winkel TA, Bax JJ et al. The obesity paradox in patients with peripheral arterial disease. Chest 2008; 134: 925–930.
Alexander RW . Inflammation and coronary artery disease. N Engl J Med 1994; 331: 468–469.
Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M . Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569–578.
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ . Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625–1638.
Acknowledgements
This work was financially supported by the UMC Utrecht Vascular Prevention Project. We gratefully acknowledge the members of the SMART Study Group of UMC Utrecht: PA Doevendans, MD, PhD, Department of Cardiology; A Algra, MD, PhD; Y van der Graaf, MD, PhD; DE Grobbee, MD, PhD; GEHM Rutten, MD, PhD, Julius Center for Health Sciences and Primary Care; LJ Kappelle, MD, PhD, Department of Neurology; WPTM Mali, MD, PhD, Department of Radiology; FL Moll, MD, PhD, Department of Vascular Surgery; FLJ Visseren, MD, PhD, Department of Vascular Medicine.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Kanhai, D., Kappelle, L., van der Graaf, Y. et al. The risk of general and abdominal adiposity in the occurrence of new vascular events and mortality in patients with various manifestations of vascular disease. Int J Obes 36, 695–702 (2012). https://doi.org/10.1038/ijo.2011.115
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ijo.2011.115
Keywords
This article is cited by
-
Efficacy of sustained delivery of GC-1 from a Nanofluidic system in a spontaneously obese non-human primate: a case study
Biomedical Microdevices (2018)
-
Relation between adiposity and vascular events, malignancy and mortality in patients with stable cerebrovascular disease
International Journal of Obesity (2017)
-
Age- and sex-specific differences in blood-borne microvesicles from apparently healthy humans
Biology of Sex Differences (2015)
-
Extracellular vesicle markers in relation to obesity and metabolic complications in patients with manifest cardiovascular disease
Cardiovascular Diabetology (2014)
-
Reproducibility of ultrasonography for assessing abdominal fat distribution in a population at high risk of diabetes
Nutrition & Diabetes (2013)


